Biomea Fusion is trading 7.32% down in pre-market at $0.60, with the cause unconfirmed.
- Available search results show no new company announcement dated October 29. The latest company press release found was October 13, reporting Phase 1 BMF-650 results.
- Nasdaq futures are down 1.25% amid concerns about technology weakness, but no evidence directly ties the broader risk-off backdrop to the stock’s decline.